SCHEMBL1226112

SCHEMBL1226112

O=C(O)C(CC(F)(F)CC1CC1)N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.43
CES1 P23141 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.31
RECQL P46063 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CNR2 P34972 1/20 0.31
TSHR P16473 1/20 0.30
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1226113 1.00 AAK1 (0.43) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL1226115 1.00 AAK1 (0.43) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL1224951 0.86 AAK1 (0.46) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL1224953 0.86 AAK1 (0.46) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL27842032 0.77 AAK1 (0.56) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL28270739 0.76 AAK1 (0.42) AAK1MEN1KMT2ABCHEACHE
SCHEMBL1224952 0.75 AAK1 (0.43) AAK1MEN1KMT2AALDH1A1RECQL
SCHEMBL16371038 0.73 AAK1 (0.68) AAK1CES1MEN1KMT2AALDH1A1
SCHEMBL17514243 0.72 AAK1 (0.53) AAK1CES1ALDH1A1NPSR1PPARG
SCHEMBL2560172 0.69 AAK1 (0.44) AAK1CES1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324417-B2 Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof VIROBAY, INC. (US) 2012-12-04 US claimed
WO-2011022429-A2 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF VIROBAY, INC. (US) 2011-02-24 WO claimed
US-20110046406-A1 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF VIROBAY, INC. (US) 2011-02-24 US claimed
US-8324417-B2 Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof VIROBAY, INC. (US) 2012-12-04 US disclosed
WO-2011022429-A2 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF VIROBAY, INC. (US) 2011-02-24 WO disclosed
US-20110046406-A1 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF VIROBAY, INC. (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046406-A1 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF DNPEP, CTRL, CTSS AAK1 1682/4885CES1 156/4885MEN1 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.